CBD can be used during chemotherapy in some circumstances, but it carries real risks of drug interactions that could change how your chemo works. The core issue is that CBD interferes with the same liver enzymes your body uses to break down many chemotherapy drugs, potentially raising or lowering drug levels in your blood in ways that are hard to predict. This makes it essential to involve your oncologist before adding CBD to your regimen.
The American Society of Clinical Oncology (ASCO) published guidelines stating that cannabis and cannabinoid use among cancer patients has outpaced the science supporting it. Their position: CBD and cannabis should not be used as a cancer treatment itself, but may have a role in managing stubborn nausea and vomiting when standard medications aren’t enough.
How CBD Interferes With Chemo Drugs
Your liver processes most chemotherapy drugs using a family of enzymes called CYP450. CBD directly inhibits several of these enzymes, including CYP3A4, CYP2D6, CYP2C9, and CYP2B6. When these enzymes are partially blocked, chemotherapy drugs that depend on them can build up in your bloodstream to higher-than-intended levels. That can mean stronger effects, but also more severe side effects.
The interaction works both ways depending on the drug. Some chemo agents are “prodrugs,” meaning the liver must convert them into their active form. If CBD slows that conversion, the drug becomes less effective. For other drugs that are already active when administered, CBD can cause them to linger longer and hit harder. The direction of the interaction depends entirely on which chemotherapy you’re receiving, which is why blanket statements about CBD and chemo don’t work.
Specific Drug Interactions Worth Knowing
Paclitaxel, a widely used chemotherapy drug, is processed by a transporter protein that CBD also targets. Combining the two may increase paclitaxel’s potency, but simultaneously increase its adverse effects. Animal studies have shown that CBD can help prevent paclitaxel-induced nerve damage in the hands and feet, one of the drug’s most common and debilitating side effects. But the same combination that reduces nerve pain could amplify other toxicities.
Docetaxel, another common chemo drug, shows similarly mixed results. In one mouse model of prostate cancer, CBD enhanced docetaxel’s tumor-fighting effects. In a different prostate cancer model, CBD appeared to slightly protect the tumor. These contradictory findings highlight how unpredictable the interaction can be depending on cancer type.
Tamoxifen, used in hormone-receptor-positive breast cancer, offers one of the more reassuring pictures. A clinical study in 15 patients found that adding CBD oil (under 50 mg daily) reduced blood levels of tamoxifen’s active form by about 12.6%. That decrease was statistically significant but remained within the range considered clinically equivalent, meaning the drug still worked as intended. Researchers concluded that good-quality CBD oil at doses below 50 mg does not need to be discouraged for patients using tamoxifen. However, patients who are slower metabolizers of tamoxifen (due to their genetic makeup) saw a larger drop in the drug’s active levels, making the interaction more concerning for that group.
CBD and Liver Strain
Many chemotherapy regimens are already hard on the liver, and CBD adds to that burden. In studies of high-dose CBD (20 mg per kilogram of body weight daily, far higher than most over-the-counter products), some patients developed elevated liver enzymes, a sign of liver stress. This was especially common when CBD was combined with other drugs known to tax the liver.
The reassuring finding is that none of these elevations met the threshold for true drug-induced liver injury. In patients who continued taking CBD despite mildly elevated enzymes, levels returned to normal on their own. Still, if your chemotherapy regimen includes drugs that are tough on the liver, adding CBD creates an additional variable your oncologist needs to monitor through routine blood work.
Where CBD May Actually Help
The strongest evidence for CBD during chemotherapy is for nausea and vomiting that persists despite standard anti-nausea medications. A randomized, placebo-controlled trial tested an oral cannabis extract containing both THC and CBD in patients whose nausea broke through standard treatment. The extract tripled the complete response rate, from 8% on placebo to 24%, with similar improvements in rescue medication use and quality-of-life scores. It’s worth noting this was a THC:CBD combination, not CBD alone, and it did come with additional side effects.
For chemotherapy-induced nerve pain, the picture is less encouraging in humans than animal studies suggested. A pilot randomized trial tested topical CBD cream on 40 patients with established nerve damage from chemo. After two weeks, pain and toxicity scores were essentially identical between the CBD group and the placebo group. The cream was well tolerated, but it didn’t improve symptoms. This was a small pilot study using a topical formulation, so it doesn’t rule out other forms of CBD, but it tempers expectations.
Immunotherapy Combinations
If your treatment plan includes immune checkpoint inhibitors alongside chemotherapy, CBD introduces another layer of complexity. Some preclinical research in colorectal cancer suggests CBD may actually enhance the effectiveness of certain immunotherapy drugs by increasing the expression of proteins these drugs target. But these findings come from lab and animal studies, not human trials. The interaction between CBD and the immune system is still poorly understood, and immune checkpoint inhibitors depend on a finely tuned immune response that cannabinoids could theoretically disrupt.
Product Quality Matters More Than Usual
Chemotherapy suppresses your immune system, making you more vulnerable to contaminants that a healthy person might shrug off. CBD products are not regulated the way pharmaceuticals are. Independent testing has repeatedly found that products contain different amounts of CBD than labeled, and some carry heavy metals, pesticides, or residual solvents. For someone with a compromised immune system, these contaminants pose a genuine risk.
If you do use CBD during treatment, look for products with third-party certificates of analysis from an independent lab. These should verify the CBD content matches the label and confirm the product has been tested for heavy metals, pesticides, and microbial contamination. Avoid products that don’t provide this documentation.
Practical Considerations
The single most important step is telling your oncologist. ASCO guidelines emphasize that clinicians should ask about cannabis use without judgment, and patients should feel comfortable disclosing it. Your oncologist can check whether your specific chemo drugs are metabolized by the enzymes CBD inhibits and whether the combination creates a meaningful risk.
Dose matters significantly. Most concerning drug interactions have been studied at high CBD doses. The tamoxifen study, which found clinically acceptable results, used doses under 50 mg daily. Many over-the-counter CBD products suggest servings in the 10 to 50 mg range, but actual content varies widely. Timing also plays a role: taking CBD and chemotherapy at the same moment may produce a larger interaction than spacing them apart, though formal dosing guidance doesn’t exist for most combinations.
If your goal is managing nausea, pain, anxiety, or sleep problems during treatment, your oncologist may be able to suggest options with better-established safety profiles. But if you’ve found that CBD helps and want to continue, the conversation with your care team is about managing risk, not an automatic prohibition.